Clinicopathological Characteristics of Breast Cancer at Cibabat Regional General Hospital in 2022–2023

Meike Rachmawati, Nuzirwan Acang, Wida Purbaningsih, Rian Robian, Adhi Nugraha, Rina Melati, Aryanti Aryanti, Aninditya Putri Anugrah, Nazmy Noor Laila

Abstract


Breast cancer is the most common malignancy found in women throughout the world and is the fifth leading cause of cancer death in the world. Cibabat Regional General Hospital is one of the places for breast cancer examination and treatment in West Java. This study aims to determine the clinical and histopathological features at Cibabat Regional General Hospital. The method used in this research is descriptive-analytic with a total sampling technique using secondary data obtained from the medical records of Cibabat Regional General Hospital patients from 2022 to June 2023. The results show that most cases of breast cancer at Cibabat Regional General Hospital occur in those aged 45–54 (32.3%), left breast (52.1%), grade 3 (44.8%), histopathological type invasive carcinoma of no special type (75%), lymph node status unknown (88.5%), negative lymphovascular invasion (43.7%), and fat invasion status unknown (68.7%). The conclusion is that breast cancer cases at Cibabat Regional General Hospital mainly occur in patients of productive age with a high grade and predominantly in the left breast, with the most common type being invasive carcinoma of no particular type.

Keywords


Breast cancer; clinicopathology

Full Text:

PDF

References


do Nascimento RG, Otoni KM. Histological and molecular classification of breast cancer: what do we know? Mastology. 2020;30:e20200024.

World Health Organization. Cancer [Internet]. Geneva: World Health Organization; 2022 Feb 3 [cited 2023 Aug 11]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Pusat Data dan Informasi Kementerian Kesehatan Republik Indonesia. Infodatin Kanker Payudara [Internet]. Jakarta: Kementerian Kesehatan Republik Indonesia; 2016 [cited 2023 Aug 11]. Available from: https://www.kemkes.go.id/article/view/17010500002/infodatin-kanker-payudara.html.

Shen SD, Zhong SZ, Wang CZ, Huang WH. Correlation of lymphovascular invasion with clinicopathological factors in invasive breast cancer: a meta-analysis. Int J Clin Exp Med. 2015; 8(10):17789–95.

Phung MT, Tin Tin S, Elwood JM. Prognostic models for breast cancer: a systematic review. BMC Cancer. 2019;19(1):230.

Fajar IM, Heriady Y, Aji HW. Karakteristik usia, gambaran klinis dan histopatologi pasien kanker payudara di RSUD Al-Ihsan Provinsi Jawa Barat periode Januari 2018–Oktober 2020. JRK. 2021;1(2):85–91.

Ervina R, Norahmawati E, Angelina A. Profil klinikopatologi karsinoma payudara di Instalasi Patologi Anatomi RSUD Dr. Saiful Anwar Malang. JK-RISK. 2021;1(1):12–21.

Shoemaker ML, White MC, Wu M, Weir HK, Romieu I. Differences in breast cancer incidence among young women aged 20–49 years by stage and tumor characteristics, age, race, and ethnicity, 2004–2013. Breast Cancer Res Treat. 2018;169(3):595–606.

Ellington TD, Miller JW, Henley SJ, Wilson RJ, Wu M, Richardson LC. Trends in breast cancer incidence, by race, ethnicity, and age among women aged ≥20 years — United States, 1999–2018. MMWR Morb Mortal Wkly Rep. 2022;71(2):43–7.

Al Saad S, Al Shenawi H, Almarabheh A, Al Shenawi N, Mohamed AI, Yaghan R. Is laterality in breast cancer still worth studying? Local experience in Bahrain. BMC Cancer. 2022;22(1):968.

Abdou Y, Gupta M, Asaoka M, Attwood K, Mateusz O, Gandhi S, et al. Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer. Sci Rep. 2022;12(1):13377.

Cheng SA, Liang LZ, Liang QL, Huang ZY, Peng XX, Hong XC, et al. Cancer management and research dovepress breast cancer laterality and molecular subtype likely share a common risk factor. Cancer Manag Res. 2018;10:6549–54.

Surabhi DM, Wilson JC, Singh M, Green L. Recognizing invasive breast carcinoma of no special type with medullary pattern. Radiol Case Rep. 2023;18(5):1788–92.

Makki J. Diversity of breast carcinoma: histological subtypes and clinical relevance. Clin Med Insights Pathol. 2015;8:23–31.

Gogia A, Deo SV, Shukla NK, Mathur S, Sharma DN, Tiwari A. Clinicopathological profile of breast cancer: an institutional experience. Indian J Cancer. 2018;55(3):210–3.

Chakraborty A, Bose CK, Basak J, Sen AN, Mishra R, Mukhopadhyay A. Determinants of lymph node status in women with breast cancer: a hospital-based study from eastern India. Indian J Med Res. 2016;143(Suppl):S45–51.

Dong X, Chunrong Y, Hongjun H, Xuexi Z. Differentiating the lymph node metastasis of breast cancer through dynamic contrast-enhanced magnetic resonance imaging. BJR Open. 2019;1(1):20180023.

Ryu YJ, Kang SJ, Cho JS, Yoon JH, Park MH. Lymphovascular invasion can be better than pathologic complete response to predict prognosis in breast cancer treated with neoadjuvant chemotherapy. Medicine (Baltimore). 2018;97(30):e11647.

Yamaguchi J, Moriuchi H, Ueda T, Kawashita Y, Hazeyama T, Tateishi M, et al. Active behavior of triple-negative breast cancer with adipose tissue invasion: a single center and retrospective review. BMC Cancer. 2021;21(1):434.




DOI: https://doi.org/10.29313/gmhc.v12i1.13462

pISSN 2301-9123 | eISSN 2460-5441


Visitor since 19 October 2016: 


Free counters!


Global Medical and Health Communication is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.